Comparison
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189 vs 3q26 Microduplication Syndrome C4755319
Clinical comparison between 46 XX Disorder OF Sex Development Induced BY Fetal Androgens Excess and 3q26 Microduplication Syndrome for differential diagnosis and treatment planning.
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189
A condition where an XX fetus produces excess male hormones, often from adrenal gland abnormalities, leading to atypical genital development. It is identified at birth. Treatment typically includes hormone therapy and possible surgery.
3q26 Microduplication Syndrome C4755319
A genetic condition involving extra genetic material at chromosome 3q26, which can cause developmental delays and other features depending on specific genes involved.
6 comparison axes
Onset
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189
0-0
3q26 Microduplication Syndrome C4755319
0-null
Onset patterns differ
Severity
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189
severe
3q26 Microduplication Syndrome C4755319
moderate
Different severity levels
Chronic
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189
Chronic
3q26 Microduplication Syndrome C4755319
Chronic
Differing course
Communicable
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189
No
3q26 Microduplication Syndrome C4755319
No
Different transmission
Body System
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189
reproductive
3q26 Microduplication Syndrome C4755319
congenital
Same/different system
Category
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189
endocrine
3q26 Microduplication Syndrome C4755319
genetic
Different category
Bottom line
46-xx-disorder-of-sex-development-induced-by-fetal-androgens-excess-C5680189 and 3q26-microduplication-syndrome-C4755319 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189 | 3q26 Microduplication Syndrome C4755319 | Discriminating power |
|---|---|---|---|
| Genital appearance at birth | Atypical genital development may be present because of fetal androgen excess. | Genital atypicality is not an established defining feature from the supplied data. | High |
| Developmental delay | Not described as a core feature in the source description. | Developmental delay may occur, depending on the genes involved. | Moderate |
| Endocrine pattern | Excess fetal androgens, often linked to adrenal abnormality, is central. | No specific androgen excess is established by the supplied description. | High |
When to favor each condition
Choose 46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189 when
XX newborn with atypical genitalia
The source centers on fetal androgen excess and genital development.
High
Suspected adrenal source of androgen excess
Adrenal abnormality is a stated possible mechanism.
Moderate
Need for endocrine rather than chromosomal framing
The supplied category is endocrine and reproductive.
Moderate
Choose 3q26 Microduplication Syndrome C4755319 when
Developmental delay with a detected 3q26 duplication
The diagnosis depends on extra material at 3q26.
High
Variable congenital features without a defined androgen disorder
Features depend on involved genes and are not limited to sex development.
Moderate
Genetic counseling after chromosomal microarray
Copy-number findings require genetics interpretation.
Moderate
How key tests differ
| Test | 46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189 | 3q26 Microduplication Syndrome C4755319 | Interpretation |
|---|---|---|---|
| Karyotype or sex-chromosome assessment | 46,XX is part of the named condition. | Sex chromosomes are not specified by the source. | A 46,XX result supports the left label but does not prove androgen excess. |
| Chromosomal microarray | No 3q26 duplication is required by the description. | Extra material at 3q26 is the defining finding. | Array results should be interpreted by a genetics clinician. |
| Androgen and adrenal evaluation | Evaluation may seek fetal or neonatal androgen excess and adrenal causes. | No characteristic androgen result is established here. | Abnormal hormones are findings, not a complete diagnosis. |
Prognosis comparison
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189
- Outcome
- Chronic endocrine and reproductive care may be needed; exact outcome is not established.
- Factors
- Cause of androgen excess, adrenal involvement, and individualized care may influence course.
3q26 Microduplication Syndrome C4755319
- Outcome
- Often chronic, with moderate but variable developmental impact.
- Factors
- Duplication size, genes involved, and associated features may affect outcome.
Time frame: Both may be recognized in infancy, but lifelong implications are not fully defined here.
Accurate testing, specialist follow-up, and associated medical needs are important.
Complications comparison
| Complication | Presentation |
|---|---|
| Atypical genital development | May be identified at birth and require specialist care. Not established as a typical complication from the source. Surgical decisions require individualized specialist counseling. |
| Hormonal imbalance | Androgen excess and possible adrenal disease may need ongoing endocrine care. A specific hormonal complication is not established. Do not infer doses or laboratory cutoffs from these data. |
| Neurodevelopmental difficulty | Not described as characteristic in the supplied source. Developmental delay and other gene-dependent features may occur. Severity and support needs vary and are not predictable here. |
Patient education highlights
- HighDifferent causes
One condition concerns androgen exposure in an XX fetus; the other is extra chromosome 3q26 material.
- HighSpecialist confirmation
Endocrine, genetics, and pediatric specialists should interpret tests and guide care.
- MediumVariable course
Features, treatment, and outcomes vary; supplied data do not establish exact prognosis.